Correction to: Current Treatment Options in Oncology (2024) 25:313-329

https://doi.org/10.1007/s11864-023-01171-3

The original online version of this article was revised as stated below:

In the section titled "Use of HIPEC in Ovarian Cancer," in the fourth paragraph, there is a line that begins, "Zivanovic et al. subsequently conducted a phase 3 trial... [45•]." On review, this reference #45 by Zivanovic et al. was actually a phase 2 trial, not phase 3.

The sentence should read as:

Zivanovic et al. subsequently conducted a phase 2 trial of HIPEC with carboplatin at secondary CRS that did not show an improvement in either PFS or OS [45•].

The original article has been corrected.